Universe Pharmaceuticals Inc SEC Filings

UPC NASDAQ

Welcome to our dedicated page for Universe Pharmaceuticals SEC filings (Ticker: UPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Universe Pharmaceuticals’ blend of Traditional Chinese Medicine and modern biomedicine creates filings dense with dual-framework manufacturing data, supply-chain disclosures, and cross-border quality standards. If you’ve searched a 300-page 10-K trying to separate TCM revenue from OTC cold remedies, you know the challenge. Stock Titan eliminates that pain: our AI ingests every submission the moment it hits EDGAR and surfaces the numbers, risks, and segment details investors look for first.

Want Universe Pharmaceuticals insider trading Form 4 transactions before the market reacts? We stream them in real time. Need the latest Universe Pharmaceuticals quarterly earnings report 10-Q filing or a headline-moving 8-K? Each document arrives here with an AI-powered summary that turns technical language into plain English—truly Universe Pharmaceuticals SEC filings explained simply. You’ll also find the full proxy—Universe Pharmaceuticals proxy statement executive compensation—alongside Universe Pharmaceuticals Form 4 insider transactions real-time alerts, ensuring nothing slips past you.

Because the company leans on both proprietary production and third-party suppliers, its disclosures uncover margins by product class, herbal sourcing data, and regulatory milestones. Use this page to:

Run a Universe Pharmaceuticals earnings report filing analysis with AI-generated trend tables.
Compare cash flows across segments through the Universe Pharmaceuticals annual report 10-K simplified.
Monitor sentiment via Universe Pharmaceuticals executive stock transactions Form 4.
See Universe Pharmaceuticals 8-K material events explained within minutes of filing.
Start understanding Universe Pharmaceuticals SEC documents with AI instead of reading page by page.

All filings, all forms, always current—backed by real-time updates and expert-level AI summaries that make due diligence fast and clear.

07/03/2025 04:05 PM

Filing

[6-K] Universe Pharmaceuticals Inc. Current Report (Foreign Issuer)

Rhea-AI Summary

Color Star Technology Co., Ltd. (NASDAQ: ADD) reported the results of its 29 June 2025 Annual General Meeting in a Form 6-K filing. Holders of 17,083,723 ordinary shares, representing 57.9 % of outstanding shares, formed a quorum and approved every agenda item.

Key resolutions:

Reverse Share Split & Share Consolidation: Board may implement a reverse split at a ratio between 1-for-5 and 1-for-100. This reduces the share count and raises the par value while keeping authorised capital at US$32 million. Vote: 99.0 % in favour (16.92 m For / 0.16 m Against).
Corporate Rebrand: Company name will change to Zeta Network Group. Vote: 99.3 % in favour (16.97 m For).
Articles Amendment: Adoption of a Seventh Amended & Restated Memorandum and Articles to reflect the share consolidation and name change (99.3 % support).
2025 Equity Incentive Plan: Authorises new share-based awards; passed with 99.1 % support.
Board Elections: Five directors (Wei Zhang, Hung-Jen Kuo, Honglei Jiang, Yan Zhang, Samantha Huang) re-elected with ~99.2 % approval each.
Auditor Ratification: Assentsure PAC retained for FY 2025 (99.5 % approval).
Routine filings and adjournment authorities also approved.

Implications for investors: The reverse split authority provides flexibility to lift a depressed share price or meet exchange listing requirements, but may compress existing shareholdings depending on the final ratio chosen. The equity plan could introduce dilution over time, while the rebrand signals a strategic repositioning. No financial performance metrics were disclosed in this filing.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the current stock price of Universe Pharmaceuticals (UPC)?

The current stock price of Universe Pharmaceuticals (UPC) is $3.27 as of July 18, 2025.

What is the market cap of Universe Pharmaceuticals (UPC)?

The market cap of Universe Pharmaceuticals (UPC) is approximately 2.1M.

What are the primary areas of expertise for Universe Pharmaceuticals Inc?

Universe Pharmaceuticals Inc specializes in Traditional Chinese Medicine derivatives and biomedical products aimed at addressing chronic health conditions and supporting elderly wellness. Its focus spans both proprietary and third-party manufactured healthcare solutions.

How does the company generate its revenue?

The company generates revenue through direct sales and strategic partnerships with third-party manufacturers. This diversified approach ensures that it taps into various market segments while maintaining a resilient business model.

What product categories does Universe Pharmaceuticals Inc offer?

The company offers products that are primarily divided into treatments for chronic conditions affecting the elderly and cold & flu medications. Additionally, it markets biomedical drugs, medical instruments, Traditional Chinese Medicine pieces, and dietary supplements.

How does Universe Pharmaceuticals address the healthcare needs of the elderly?

The company focuses on developing and distributing products that target chronic health conditions common among the elderly, aiming to promote physical well-being and longevity. It leverages a blend of traditional remedies and modern biomedical approaches to meet these needs.

In what ways does the company differentiate itself from competitors?

Universe Pharmaceuticals Inc distinguishes itself by integrating Traditional Chinese Medicine with contemporary biomedical products. This dual approach allows it to offer unique healthcare solutions that cater specifically to the elderly, setting it apart in a crowded market.

How are third-party products integrated into the company’s portfolio?

The company supplements its in-house product lines by marketing high-quality, third-party manufactured biomedical drugs, medical instruments, and dietary supplements. This integration expands its offerings while ensuring adherence to strict quality and safety standards.

What measures does Universe Pharmaceuticals take to ensure quality and regulatory compliance?

The company adheres to rigorous manufacturing and testing protocols to ensure that all products, whether developed internally or sourced externally, meet high-quality standards. This focus on compliance and quality assurance helps maintain customer trust and regulatory reliability.

How does Universe Pharmaceuticals maintain its market position amid industry challenges?

By leveraging a diversified product portfolio and maintaining strong partnerships with external manufacturers, Universe Pharmaceuticals Inc adapts to changing industry dynamics. Its strategic focus on elderly wellness and consistent quality control further strengthens its position in the market.